{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:22:45Z","timestamp":1762867365067,"version":"3.37.3"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"DAAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jtbi.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T09:52:00Z","timestamp":1517565120000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intermittent treatment of severe influenza"],"prefix":"10.1016","volume":"442","author":[{"given":"Lucas","family":"Deecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana M.","family":"Dobrovolny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2018.01.012_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.05.006","article-title":"The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models","volume":"132","author":"Abed","year":"2016","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0002","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/344237","article-title":"Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene","volume":"186","author":"Abed","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0003","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.jtbi.2018.01.012_bib0004","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans","volume":"80","author":"Baccam","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.jtbi.2018.01.012_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors","volume":"89","author":"Baek","year":"2015","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.jtbi.2018.01.012_bib0006","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.jtbi.2018.01.012_bib0007","doi-asserted-by":"crossref","first-page":":S7","DOI":"10.1186\/1471-2458-11-S1-S7","article-title":"A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead","volume":"11","author":"Beauchemin","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0008","doi-asserted-by":"crossref","first-page":"42765","DOI":"10.1038\/srep42765","article-title":"Duration of SHIV production by infected cells is not exponentially distributed: implications for estimates of infection parameters and antiviral efficacy","volume":"7","author":"Beauchemin","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jtbi.2018.01.012_bib0009","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1172\/JCI45961","article-title":"The three R\u2019s of lung health and disease: repair, remodeling, and regeneration","volume":"121","author":"Beers","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5983","key":"10.1016\/j.jtbi.2018.01.012_bib0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0011","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza a viruses isolated early during the 2005\u20132006 influenza season in the united states","volume":"295","author":"Bright","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jtbi.2018.01.012_bib0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jac\/dkq486","article-title":"Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness","volume":"66","author":"Brookes","year":"2011","journal-title":"J. Antimicrob. Ther."},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0013","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcv.2014.07.004","article-title":"Prolonged shedding of pandemic influenza a (H1N1) 2009 virus in a pancreas-after-kidney transplant recipient","volume":"61","author":"Bruminhent","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0014","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1128\/JVI.02473-14","article-title":"Competitive fitness of influenza b viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium","volume":"89","author":"Burnham","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jtbi.2018.01.012_bib0015","doi-asserted-by":"crossref","first-page":"e1004065","DOI":"10.1371\/journal.ppat.1004065","article-title":"Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1) pdm09 influenza viruses","volume":"10","author":"Butler","year":"2014","journal-title":"PLOS Path"},{"issue":"4","key":"10.1016\/j.jtbi.2018.01.012_bib0016","doi-asserted-by":"crossref","first-page":"e1003568","DOI":"10.1371\/journal.pcbi.1003568","article-title":"Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study","volume":"10","author":"Canini","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.jtbi.2018.01.012_bib0017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2013.03.003","article-title":"Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses","volume":"178","author":"Chan","year":"2013","journal-title":"Virus Res."},{"issue":"6629","key":"10.1016\/j.jtbi.2018.01.012_bib0018","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jtbi.2018.01.012_bib0019","doi-asserted-by":"crossref","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","article-title":"Epithelial repair mechanisms in the lung","volume":"298","author":"Crosby","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"year":"1991","series-title":"The Lung: Scientific Foundations","author":"Crystal","key":"10.1016\/j.jtbi.2018.01.012_bib0020"},{"issue":"4","key":"10.1016\/j.jtbi.2018.01.012_bib0021","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"Dahari","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jtbi.2018.01.012_bib0022","doi-asserted-by":"crossref","first-page":"e0173577","DOI":"10.1371\/journal.pone.0173577","article-title":"Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection","volume":"12","author":"de Bree","year":"2017","journal-title":"Plos One"},{"issue":"10","key":"10.1016\/j.jtbi.2018.01.012_bib0023","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Local and systemic cytokine responses during experimental human influenza A virus infection","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jtbi.2018.01.012_bib0024","doi-asserted-by":"crossref","first-page":"e13811","DOI":"10.1371\/journal.pone.0013811","article-title":"Exploring cell tropism as a possible contributor to influenza infection severity","volume":"5","author":"Dobrovolny","year":"2010","journal-title":"Plos ONE"},{"issue":"7","key":"10.1016\/j.jtbi.2018.01.012_bib0025","doi-asserted-by":"crossref","first-page":"e0180582","DOI":"10.1371\/journal.pone.0180582","article-title":"Modelling the emergence of influenza drug resistance: the roles of surface proteins, the immune response and antiviral mechanisms","volume":"12","author":"Dobrovolny","year":"2017","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0026","doi-asserted-by":"crossref","first-page":"e57088","DOI":"10.1371\/journal.pone.0057088","article-title":"Assessing mathematical models of influenza infections using features of the immune response","volume":"8","author":"Dobrovolny","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jtbi.2018.01.012_bib0027","doi-asserted-by":"crossref","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza A viruses in the world (1902-2013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.jtbi.2018.01.012_bib0028","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.90.9.4171","article-title":"Rates of spontaneous mutation among rna viruses.","volume":"90","author":"Drake","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.jtbi.2018.01.012_bib0029","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/AAC.03667-14","article-title":"Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient","volume":"58","author":"Eshaghi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/j.jtbi.2018.01.012_bib0030","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e328311d16f","article-title":"Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"22","author":"Fox","year":"2008","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.jtbi.2018.01.012_bib0031","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/infdis\/jis571","article-title":"Presence of oseltamivir-resistant pandemic A\/H1N1 minor variants before drug therapy with subsequent selection and transmission","volume":"206","author":"Ghedin","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"16","key":"10.1016\/j.jtbi.2018.01.012_bib0032","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/QAD.0b013e32835844d9","article-title":"Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM trial","volume":"26","author":"Goujard","year":"2012","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.jtbi.2018.01.012_bib0033","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/JVI.00689-10","article-title":"Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model","volume":"84","author":"Govorkova","year":"2010","journal-title":"J. Virol."},{"issue":"9206","key":"10.1016\/j.jtbi.2018.01.012_bib0034","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubareva","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jtbi.2018.01.012_bib0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/apc.2012.0439","article-title":"Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: Implications for \u2019test and treat\u2019 prevention strategy","volume":"27","author":"Guy","year":"2013","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0036","doi-asserted-by":"crossref","first-page":"e43754","DOI":"10.1371\/journal.pone.0043754","article-title":"Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection","volume":"7","author":"Hamlyn","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0037","series-title":"Antiviral Drug Resistance","first-page":"43","article-title":"Amantadine and rimantadine \u2013 mechanisms","author":"Hay","year":"1996"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0038","unstructured":"Hayden, F.G., 1996. Amantadine and rimantadine \u2013 clinical aspects. Antiviral Drug Resistance. John Wiley & Sons Ltd, 59\u201377."},{"issue":"9","key":"10.1016\/j.jtbi.2018.01.012_bib0039","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets","volume":"190","author":"Herlocher","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"S1","key":"10.1016\/j.jtbi.2018.01.012_bib0040","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2458-11-S1-S10","article-title":"Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture","volume":"11","author":"Holder","year":"2011","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.jtbi.2018.01.012_bib0041","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s13160-016-0227-7","article-title":"Modelling and optimal control of a nonlinear switched system in microbial continuous fermentation","volume":"33","author":"Hu","year":"2016","journal-title":"Jpn. J. Ind. Appl. Math."},{"issue":"3","key":"10.1016\/j.jtbi.2018.01.012_bib0042","doi-asserted-by":"crossref","first-page":"1601710","DOI":"10.1183\/13993003.01710-2016","article-title":"Tropism and innate host responses of influenza A\/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract","volume":"49","author":"Hui","year":"2017","journal-title":"Eur. Resp. J."},{"issue":"6","key":"10.1016\/j.jtbi.2018.01.012_bib0043","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/irv.12108","article-title":"Progressive emergence of an oseltamivir-resistant A (H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient","volume":"7","author":"Hurt","year":"2013","journal-title":"Influenza Resp. Viruses"},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0044","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo","volume":"55","author":"Ives","year":"2002","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0045","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3390\/v6083159","article-title":"Options and obstacles for designing a universal influenza vaccine","volume":"6","author":"Jang","year":"2014","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0046","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1038\/srep10371","article-title":"A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain","volume":"5","author":"Kakizoe","year":"2015","journal-title":"Sci. Rep."},{"year":"1992","series-title":"Numerical Solution of Stochastic Differential Equations","author":"Kloeden","key":"10.1016\/j.jtbi.2018.01.012_bib0047"},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0048","doi-asserted-by":"crossref","first-page":"e1001301","DOI":"10.1371\/journal.pgen.1001301","article-title":"Prevalence of epistasis in the evolution of influenza a surface proteins","volume":"7","author":"Kryazhimskiy","year":"2011","journal-title":"PLoS Genet."},{"issue":"44","key":"10.1016\/j.jtbi.2018.01.012_bib0049","doi-asserted-by":"crossref","first-page":"18638","DOI":"10.1073\/pnas.0905497106","article-title":"The dynamics of adaptation on correlated fitness landscapes","volume":"106","author":"Kryazhimskiy","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.jtbi.2018.01.012_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1109\/37.793443","article-title":"Basic problems in stability and design of switched systems","volume":"19","author":"Liberzon","year":"1999","journal-title":"IEEE Control Sys. Mag."},{"key":"10.1016\/j.jtbi.2018.01.012_bib0051","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bcp.2017.07.023","article-title":"Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin","volume":"144","author":"Lin","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0052","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1086\/529523","article-title":"Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up","volume":"197","author":"Lundgren","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.jtbi.2018.01.012_bib0053","first-page":"e27047","article-title":"Optimal antiviral switching to minimize resistance risk in HIV therapy","volume":"6","author":"Luo","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"6193","key":"10.1016\/j.jtbi.2018.01.012_bib0054","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-139-2-200307150-00007","article-title":"Alternation of antiretroviral drug regimens for HIV infection. a randomized, controlled trial","volume":"139","author":"Martinez-Picado","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.jtbi.2018.01.012_bib0056","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the mutation rates of human influenza A and B viruses","volume":"80","author":"Nobusawa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2018.01.012_bib0057","doi-asserted-by":"crossref","first-page":"40210","DOI":"10.1038\/srep40210","article-title":"The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients","volume":"7","author":"Palmer","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.jtbi.2018.01.012_bib0058","doi-asserted-by":"crossref","first-page":"e0126115","DOI":"10.1371\/journal.pone.0126115","article-title":"Impact of the H275Y and I223V mutations in the neuraminidase of the 2009 pandemic influenza virus in vitro and evaluating experimental reproducibility","volume":"10","author":"Paradis","year":"2015","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.jtbi.2018.01.012_bib0059","doi-asserted-by":"crossref","first-page":"e0159847","DOI":"10.1371\/journal.pone.0159847","article-title":"Competitive fitness of influenza B viruses possessing E119A and H274Y neuraminidase inhibitor resistance-associated substitutions in ferrets","volume":"11","author":"Pascua","year":"2016","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.jtbi.2018.01.012_bib0060","doi-asserted-by":"crossref","first-page":"e23232","DOI":"10.1371\/journal.pone.0023232","article-title":"Age-dependent decline in mouse lung regeneration with loss of lung fibroblast clonogenicity and increased myofibroblastic differentiation","volume":"6","author":"Paxson","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0061","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/infdis\/jis265","article-title":"Combination antiviral therapy for influenza: predictions from modeling of human infections","volume":"205","author":"Perelson","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"19","key":"10.1016\/j.jtbi.2018.01.012_bib0062","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1128\/JVI.07244-11","article-title":"The H275Y neuraminidase mutation of the pandemic A\/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets","volume":"86","author":"Pinilla","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.jtbi.2018.01.012_bib0063","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jcv.2014.10.014","article-title":"Novel triple reassortant H1N2 influenza viruses bearing six internal genes of the pandemic 2009\/H1N1 influenza virus were detected in pigs in China","volume":"61","author":"Qiao","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jtbi.2018.01.012_bib0064","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1743-422X-8-346","article-title":"Human cell types important for hepatitis C virus replication in vivo and in vitro. old assertions and current evidence","volume":"8","author":"Revie","year":"2011","journal-title":"Virol. J."},{"issue":"19","key":"10.1016\/j.jtbi.2018.01.012_bib0065","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jtbi.2018.01.012_bib0066","first-page":"875028","article-title":"CD8+ T-cell responses before and after structured treatment interruption in Ugandan adults who initiated ART with CD4+ T cells \u00a1200 cell\/mu L: the DART trial STI substudy","author":"Serwanga","year":"2011","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.jtbi.2018.01.012_bib0067","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"issue":"11","key":"10.1016\/j.jtbi.2018.01.012_bib0068","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/14787210.2014.966083","article-title":"A review of neuraminidase inhibitor susceptibility in influenza strains","volume":"12","author":"Spanakis","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"2","key":"10.1016\/j.jtbi.2018.01.012_bib0069","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAD.0b013e3282f2d760","article-title":"Fixed duration interruptions are inferior to continuous treatment in african adults starting therapy with CD4 cell counts \u00a1 200 cells\/mu l","volume":"22","author":"Walker","year":"2008","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jtbi.2018.01.012_bib0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coviro.2012.07.007","article-title":"Viral fitness: definitions, measurement, and current insights","volume":"2","author":"Wargo","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"5","key":"10.1016\/j.jtbi.2018.01.012_bib0071","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1128\/JVI.02163-13","article-title":"Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011","volume":"88","author":"Westgeest","year":"2014","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.jtbi.2018.01.012_bib0072","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00985-12","article-title":"Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation","volume":"86","author":"Wong","year":"2012","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.jtbi.2018.01.012_bib0073","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JVI.80.5.2380-2389.2006","article-title":"Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.jtbi.2018.01.012_bib0074","doi-asserted-by":"crossref","first-page":"1450114","DOI":"10.1142\/S0218127414501144","article-title":"Discrete switching host-parasitoid models with integrated pest control","volume":"24","author":"Xiang","year":"2014","journal-title":"Int. J. Bifur. Chaos"},{"key":"10.1016\/j.jtbi.2018.01.012_bib0075","doi-asserted-by":"crossref","first-page":"8627613","DOI":"10.1155\/2016\/8627613","article-title":"Numerical analysis of discrete switching prey-predator model for integrated pest management","volume":"2016","author":"Xiang","year":"2016","journal-title":"Discrete Dyn. Nat. Soc."},{"issue":"4","key":"10.1016\/j.jtbi.2018.01.012_bib0076","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/JCM.01532-09","article-title":"Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A\/H1N1 viruses","volume":"48","author":"Zaraket","year":"2010","journal-title":"J. Clin. Microbiol."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519318300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519318300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T07:52:19Z","timestamp":1575359539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519318300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":76,"alternative-id":["S0022519318300201"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2018.01.012","relation":{},"ISSN":["0022-5193"],"issn-type":[{"type":"print","value":"0022-5193"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent treatment of severe influenza","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}